Catalyst Event
Abbott Laboratories (ABT) · Other
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
4/15/2026, 12:00:00 AM
Quarterly dividend ex-date of $0.63 per share on 2026-04-15, for which a ≥1% price impact is estimated, scheduled.
Korean Translation
2026년 4월 15일 주당 0.63달러의 분기 배당 배당락일이 예정됨. 배당에 따른 1% 이상의 주가 영향이 예상됨.
Related Recent Events
Lululemon Athletica Inc (LULU) · Earnings Release
Q1 2026 earnings release scheduled. This is an estimated date based on past reporting schedules.
5/28/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q1 2026 earnings release with adjusted EPS guidance of $1.12 to $1.18, for which a ≥1% price impact is estimated, scheduled.
4/15/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
New target action date for the FDA's decision on oral obesity drug orforglipron, following an extension of the review period announced on January 15, 2026, scheduled; a price impact of at least 1% is expected.
4/10/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Other
Quarterly dividend of $1.25 per share, a 3% increase, will have its ex-dividend date on March 27, 2026. The dividend is payable on April 10, 2026. A 1% price impact is estimated due to the dividend increase, scheduled.
3/27/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
Announced positive topline results from the TRANSCEND-T2D-1 Phase 3 trial for its investigational drug retatrutide, which showed significant reductions in A1C and body weight for adults with type 2 diabetes; a price impact of over 10% is estimated.
3/19/2026, 12:00:00 AM